These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16691112)

  • 21. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroimaging in multiple sclerosis.
    Ali EN; Buckle GJ
    Neurol Clin; 2009 Feb; 27(1):203-19, ix. PubMed ID: 19055980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF; Martin R
    Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis - a response-to-damage model.
    't Hart BA; Hintzen RQ; Laman JD
    Trends Mol Med; 2009 Jun; 15(6):235-44. PubMed ID: 19451035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple sclerosis mimics.
    Herndon RM
    Adv Neurol; 2006; 98():161-6. PubMed ID: 16400833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seeing is believing: in vivo evolution of multiple sclerosis pathology with magnetic resonance.
    Ge Y
    Top Magn Reson Imaging; 2006 Aug; 17(4):295-306. PubMed ID: 17415002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach.
    Zivadinov R; Minagar A
    J Neurol Sci; 2009 Jul; 282(1-2):1-4. PubMed ID: 19345379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The history of multiple sclerosis: the changing frame of the disease over the centuries.
    Murray TJ
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S3-8. PubMed ID: 19200863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
    Stojkov D; Lavrnja I; Pekovic S; Dacic S; Bjelobaba I; Mostarica-Stojkovic M; Stosic-Grujicic S; Jovanovic S; Nedeljkovic N; Rakic L; Stojiljkovic M
    J Neurol Sci; 2008 Apr; 267(1-2):76-85. PubMed ID: 17996253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
    Filippi M; Agosta F
    Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
    Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early treatment of multiple sclerosis to prevent neurologic damage.
    Coyle PK
    Neurology; 2008 Dec; 71(24 Suppl 3):S3-7. PubMed ID: 19064872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.
    Mirowska-Guzel D
    Immunopharmacol Immunotoxicol; 2009; 31(1):32-8. PubMed ID: 18792835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The insulin-like growth factor system in multiple sclerosis.
    Chesik D; Wilczak N; De Keyser J
    Int Rev Neurobiol; 2007; 79():203-26. PubMed ID: 17531843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of cortical multiple sclerosis.
    Zarei M
    J Neurol Sci; 2006 Jun; 245(1-2):53-8. PubMed ID: 16626743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complex etiology of multiple sclerosis.
    Winquist RJ; Kwong A; Ramachandran R; Jain J
    Biochem Pharmacol; 2007 Nov; 74(9):1321-9. PubMed ID: 17537409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histo-clinical variation in multiple sclerosis: Heterogeneous proteolytic immunogenic processing.
    Westall FC
    Med Hypotheses; 2006; 66(3):566-9. PubMed ID: 16236458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evolution and surveillance of multiple sclerosis].
    Edan G; Coustans M
    Rev Prat; 1999 Nov; 49(17):1866-71. PubMed ID: 10598502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetization transfer MRI in multiple sclerosis.
    Filippi M; Agosta F
    J Neuroimaging; 2007 Apr; 17 Suppl 1():22S-26S. PubMed ID: 17425730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Picturing multiple sclerosis: conventional and diffusion tensor imaging.
    Fox RJ
    Semin Neurol; 2008 Sep; 28(4):453-66. PubMed ID: 18843574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.